Article

Hybrid contact lens receives FDA nod

Carlsbad, CA—The FDA has given SynergEyes Inc. approval to market SynergEyes A hybrid contact lenses to correct hyperopic, myopic, and astigmatic errors, including presbyopia.

The lens features a high-Dk rigid gas-permeable (RGP) center with a hydrophilic, non-ionic soft skirt and will correct ametropia from –20 to 20 D with up to 6 D of astigmatism. A patent-pending HyperBond junction technology provides a strong interface between the soft and rigid portions of the lens, the company said.

SynergEyes, which plans a fall launch, said the lens offers the visual acuity of an RGP lens and the all-day comfort of a soft lens. It plans to expand its hybrid lens line to include lenses specifically for patients with keratoconus, presbyopia, and post-surgical vision correction needs.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.